North East and North Cumbria
ICS Formulary
ICS Formulary
2 Cardiovascular system
02-03 Anti-arrhythmic drugs
| Magnesium Sulphate Injection |
|
Formulary
|
 MHRA Drug Safety Update (May 2019): Magnesium sulfate: risk of skeletal adverse effects in the neonate following prolonged or repeated use in pregnancy |
|
Links
- Academic Health Science Network (North East and North Cumbria) - Atrial Fibrilation
- County Durham and Darlington DVT Pathway Information
- County Durham and Tees Valley Prescribing Guideline for the Use of Anticoagulants in Non-Valvular Atrial Fibrillation
- MHRA Drug Safety Update (May 2019): Magnesium sulfate: risk of skeletal adverse effects in the neonate following prolonged or repeated use in pregnancy
- NICE NG148: Acute kidney injury: prevention, detection and management
- NICE NG191: COVID-19 rapid guideline: managing COVID-19
- North Cumbria - Cardiovascular workplan 2022
- South Tees Hospitals Cardiology drug prescribing guidelines & formulary